Drug-eluting stents: the past, present, and future. (Q38344198)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

review article

1 reference

title

Drug-eluting stents: the past, present, and future (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Gregory Katz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Bhisham Harchandani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

1 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

Current Atherosclerosis Reports

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651784%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11883-014-0485-2

29 February 2020

exact match

0 references

cites work

Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a systematic overview of randomized trials in light of the drug-eluting stent era.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

An Internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

New frontiers in cardiology: drug-eluting stents: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Stent thrombosis in randomized clinical trials of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Everolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Co

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Stent longitudinal integrity bench insights into a clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Should we avoid ostial implantations of Wiktor stents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Longitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: predisposing mechanical properties, incidence, and predictors in a large patient cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea r

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0485-2

Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization

21 January 2018

1 reference

12 December 2020

2-Year Patient-Related Versus Stent-Related Outcomes

1 reference

12 December 2020

Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial

1 reference

12 December 2020

Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial

1 reference

12 December 2020

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

1 reference

12 December 2020

Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms

1 reference

12 December 2020

Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents

1 reference

12 December 2020

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial

1 reference

12 December 2020

Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial)

1 reference

12 December 2020

Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent

1 reference

12 December 2020

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.

1 reference

12 December 2020

Comparison of the heparin coated vs the uncoated Jostent--no influence on restenosis or clinical outcome

1 reference

12 December 2020

Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)

1 reference

12 December 2020

Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial

1 reference

12 December 2020

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

1 reference

12 December 2020

ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the

1 reference

12 December 2020

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.

1 reference

12 December 2020

Comparative efficacy of 2 zotarolimus-eluting stent generations: Resolute versus endeavor stents in patients with coronary artery disease

1 reference

12 December 2020